Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
Portrazza PubMed™ News
Portrazza Patient Education
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Portrazza FAQs
Portrazza is available in 1 dosages, including 16 mg/ml Injection 50 ml
Portrazza treats Carcinoma, Non-Small-Cell Lung
Portrazza contains necitumumab which is a Epidermal Growth Factor Receptor Antagonist
Portrazza is administered as a Injectable
Portrazza mechanism of action is HER1 Antagonists
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
